HopeStage
Back to overview

ADHD studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 109-120 of 1,811
Drug study icon
CompletedNCT05278104

A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

Double-blind, Randomized, Parallel Group, Placebo Controlled Clinical Trial to Evaluate the Effects of Atomoxetine on Impulsivity in Behavioral Laboratory Tasks in Adult ADHD Patients

This study has finished and is no longer accepting participants.

Multiple locations, including Aachen
ADHDMedication studyAges 18–45
Countries
Germany
Sponsor
Boehringer Ingelheim
Device study icon
CompletedNCT04003740

TDCS for Inattention Symptoms in Adult ADHD Patients

Official study title

Transcranial Direct Current Stimulation for the Treatment of Inattention Symptoms in Attention-deficit/Hyperactivity Disorder: a Randomized, Double-blind, Parallel, Controlled Clinical Trial (TUNED Trial)

This study has finished and is no longer accepting participants.

In Porto Alegre
ADHDDevice studyAges 18+
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Drug study icon
RecruitingNCT05957055

Lisdexamfetamine and methylphenidate compared in children with ADHD and type 1 diabetes

About this title

Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes

Read the official source — NCT05957055
Official study title

LAMAinDiab - Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes - a Randomized Cross-over Clinical Trial

In Lodz
ADHDMedication studyAges 8 years–198 months
Countries
Poland
Sponsor
Medical University of Lodz
Drug study icon
RecruitingNCT06871488

Brain markers and stimulant treatment response in children with ADHD

About this title

Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants

Read the official source — NCT06871488
Official study title

Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth With ADHD

In Hershey
ADHDMedication studyAges 7–12
Countries
United States
Sponsor
Milton S. Hershey Medical Center
Drug study icon
Not Yet RecruitingNCT04519008

Effectiveness and Security Testing of a Mobile App

Official study title

Effectiveness and Security Testing of a Mobile App (B·RIGHT) for Adolescents With Attention-Deficit/Hyperactivity Disorder and Emotion Dysregulation

This study isn't recruiting yet.

Remote / online
ADHDDevice studyAges 14–17
Countries
Sponsor
Consorci Sanitari del Maresme
Device study icon
Enrolling By InvitationNCT07182344

Brain Stimulation and Attention Control in Children With ADHD

Official study title

Effects of iTBS on Cognitive Control in Children With ADHD: A Randomized, Sham-Controlled Study Integrating EEG During ANT, fNIRS, MRI, and Genetic Markers

This study is by invitation only.

In Almaty
ADHDDevice studyAges 6–12
Countries
Kazakhstan
Sponsor
Neurolab Plus

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.